News

First direct evidence that zinc oxide nanoparticles used in sunscreen neither penetrate the skin nor cause cellular toxicity after repeated applications.

Due to centrifugal force, humans and other animals tend to slow down when we approach a turn. Professor Mandyam Srinivasan's lab is the first to mathematically analyse the relationship between speed, curvature, and centrifugal force in this phenomenon. Their study used a high-speed-multi-camera system to capture video footage of bees loitering outside their hive.

The lucrative truffle industry is set to disappear within a generation due to climate change.

Three people with paralysis participating in the BrainGate clinical trial, an effort that includes Brown University researchers, chatted with family and friends, shopped online and used other tablet computer applications, all by just thinking about pointing and clicking a mouse.

An assessment of screening tools for identifying sepsis is pregnancy has revealed that they each have vastly different sensitivities and specificities. The study points to simple interventions that could reduce the number of maternal deaths.

Hematopoietic Stem and Progenitor Cells (HSPCs) give rise to all blood lineages that support people’s life and like seeds, need a suitable microenvironment to maintain their function.

Loss of a protein called TRIM29 promotes cancer cell invasion in a common type of skin cancer, suggesting a novel diagnostic marker and a possible therapeutic target.

Scientists have now developed a nanoplatform that selectively delivers small hairpin RNA transcription templates and chemotherapeutics into multidrug-resistant tumors. A deadly cocktail of gene-silencing elements and chemotherapeutic drugs effectively and selectively kills cells.

Machine learning – a field of artificial intelligence that uses statistical techniques to enable computer systems to ‘learn’ from data – can be used to analyse electronic health records and predict the risk of emergency hospital admissions, a new study from The George Institute for Global Health at the University of Oxford has found.

Mounting evidence shows that Epstein-Barr virus (EBV) plays a role in the pathology of multiple sclerosis. Consequently, an EBV-specific T Cell therapy has been developed to combat MS, and initial clinical trial results are promising.